• 2020 GAPNA Pharmacology Conference: Contemporary Pharmacology and Prescribing in Older AdultsJoin us at the 2020 GAPNA Pharmacology Conference:
    Contemporary Pharmacology and Prescribing in Older Adults

    April 14-18, 2020, Honolulu, HI.

    Earn up to 18 CNE hours.

     

    Find out more about it and REGISTER today!

  • AwardNew for GAPNA members: MCM Education

    GAPNA has partnered with a MCM Education to offer an ongoing series of CNE programs available to GAPNA members. "Diagnosing and Managing Parkinson’s Disease in Older Adults," is the latest program offered.

    Parkinson’s disease (PD) is characterized by both motor and nonmotor symptoms. It is diagnosed based on the presence of two of four motor symptoms including rest tremor, bradykinesia, rigidity, and gait imbalance...

    Find out about it!

  • ConventionCALL FOR: Podium and Poster Abstracts

    For the 38th GAPNA Annual Conference
    at the Hyatt Regency
    New Orleans, LA, September 24-26, 2020

    GAPNA members are invited to submit an abstract about their innovative work, that should enrich the APRN's knowledge and/or enhance the care of an older adult.

    Find out more info and deadline dates

  • FREE CE for GAPNA MembersFREE continuing education credit is available for the following session:

    "Update in Chronic Kidney Disease Management and Prescribing"

    (session captured at the GAPNA 2018 Annual Conference)


    For January/February 2020 - Get Your Free CNE Now!

  • Online CEThe Best of 2019!

    A LIVE rebroadcast event featuring 5 of GAPNA's Best CE sessions from 2019

    January 21, 2020 from 11:30 am - 5:15 pm EST

    $39 for GAPNA Members $59 for Non-Members

     

    Register Now

High-Risk Drugs Used by the Elderly Declined with Medicare Part D Coverage

Patients who moved from no drug coverage to Medicare Part D drug coverage increased their use of medications deemed Drugs to Avoid in the Elderly (DAE) from 15.72% to 17.61%.

However, the proportion of DAE in overall drug use declined slightly from 3.01% to 1.98%, according to a new study.

The proportion of drug-disease interactions remained stable. Medicare Part D, implemented in 2006, brought drug coverage to 28 million beneficiaries who either lacked it previously or had higher out-of-pocket costs, increased prescription drug use, and resulted in greater adherence to drug treatment for chronic diseases.

The researchers suggest that to maximize the potential for Part D to improve the quality of medication use among older adults, additional changes to pharmacy benefit design (e.g., cost sharing) and health professional education may be necessary.

More details are in Donohue et al. (2012). Medicare Part D and potentially inappropriate medication use in the elderly. The American Journal of Managed Care, 18(9), e315-e322.

Related Topic 1: 

GAPNA Newsletter Issue: 

VIEW ALL ARTICLES: